TG02 Citrate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TG02 Citrate, covering 2016-05-06 to 2016-05-06. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies [Phase 1]